Poultry Diagnostics MarketSize and Trends

The global poultry diagnostics market is estimated to be valued at US$ 536.7 million in 2023 and is expected to exhibit a CAGR of 11.4% during the forecast period (2023-2030).

Global Poultry Diagnostics Market Segmentation:

The global poultry diagnostics market report is segmented into Test Type, Disease Type, End User, and Region

Based on Test Type, the market is segmented into ELISA (Enzyme-Linked Immunosorbent Assay), PCR (Polymerase Chain Reaction), and Others (Direct Agglutination Test, etc.). Out of which, the PCR (Polymerase Chain Reaction) segment is expected to dominate the poultry diagnostics market during the forecast period and this is due to the increasing launch of ELISA (Enzyme-Linked Immunosorbent Assay) test over the forecast period.

Based on Disease Type, the market is segmented into Avian Salmonellosis, Avian Influenza, Newcastle Disease, Infectious Bronchitis, Infectious Bursal Disease, Others (Chicken Anemia, Avian Mycoplasmosis, etc.) segment is expected to dominate the poultry diagnostics market during the forecast period and this is due to the increasing prevalence of Avian Salmonellosis over the forecast period.

Based on End User, the poultry diagnostics market is segmented into Veterinary Hospitals, Veterinary Clinics, Veterinary Diagnostic Centers. Veterinary Hospitals segment is expected to dominate the market over the forecast period and this is due to the increasing number of Veterinary Hospitals

Among all segmentation, test type segment has the highest potential due to the increasing launch of ELISA (Enzyme-Linked Immunosorbent Assay) test in North America region.

Global Poultry Diagnostics Market Cross Sectional Analysis:

In type segment, PCR test holds a dominant segment due to the increasing usage PCR test. For instance, in December 2020, a study was conducted to compare and evaluate the effect PCR test for poultry diagnostics test. The PCR test and into ELISA (Enzyme-Linked Immunosorbent Assay were operated in two different modes after PCR test had shown more positive effect for diagnostics purpose .

Increasing adoption of inorganic growth strategies such as product launch by key market players is expected to drive the global poultry diagnostics market over the forecast period. For instance, in October 2020, Boehringer Ingelheim International GmbH, a human, animal and poultry healthcare company, announced that they had launched VAXXITEK HVT+IBD+ILT, trivalent vaccine that protects the poultry from Infectious Laryngotracheitis, Marek's Disease and Infectious Bursal Disease (classic and variant types).